This is a FACT I met up with GK at the Melbourne Open House At that time he was full of confidence that Epicursen was a WINNER.. He had more shares than Diamond and myself.. A great deal to gain… Since the drug failed he has more to lose than Diamond and myself
Heres the thing… All of a sudden he thinks he can judge whether a drug has merit… going to rely on Biotech consultants .. while drawing a huge salary..$$ himself. And the same goes for Peters…
PVL : I have no idea what their end game is ..
PER has made many good contacts re Funds and Pharmas
Dmd was the main focus….i repeat myself DMD was the main Focus …
Which explains why JG is working hard to restore Shareholder wealth…with Data generated from Atl 1102
Don’t vote with bitterness and envy in your hearts.. it’s your hard earned $$$$
PER Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)